Paper23946647
Language impairment in Alzheimer's disease and benefits of acetylcholinesterase inhibitors.
Ferris SH and 1 other. Clin Interv Aging, 2013. Cited by 82 papers, by iCite.
Cite this record
ConductScience Library. Language impairment in Alzheimer's disease and benefits of acetylcholinesterase inhibitors. Papers, record 23946647. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23946647
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Language impairment in Alzheimer's disease and benefits of acetylcholinesterase inhibitors.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Cholinesterase Inhibitors | Major topic |
| Communication Disorders | Major topic |
| Donepezil | |
| Galantamine | |
| Humans | |
| Indans | |
| Outcome Assessment, Health Care | |
| Phenylcarbamates | |
| Piperidines | |
| Rivastigmine |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P30 AG008051 | NIA NIH HHS | United States | P30AG008051 | PubMed and NIH |
Source NIH RePORTER
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21131668 | Reviews: Effects of transdermal rivastigmine on ADAS-cog items in mild-to-moderate Alzheimer's disease. | Am J Alzheimers Dis Other Demen | 2010 | https://conductscience.org/library/papers/21131668 | PubMed |
| 2 | 15306548 | The effects of ageing and Alzheimer's disease on semantic and gender priming. | Brain | 2004 | https://conductscience.org/library/papers/15306548 | PubMed |
| 3 | 16209425 | Detailed assessment of activities of daily living in moderate to severe Alzheimer's disease. | J Int Neuropsychol Soc | 2005 | https://conductscience.org/library/papers/16209425 | PubMed |
| 4 | 20395684 | Cognition and function in Alzheimer's disease: identifying the transitions from moderate to severe disease. | Dement Geriatr Cogn Disord | 2010 | https://conductscience.org/library/papers/20395684 | PubMed |
| 5 | 22119074 | What are the important factors in health-related quality of life for people with aphasia? A systematic review. | Arch Phys Med Rehabil | 2012 | https://conductscience.org/library/papers/22119074 | PubMed |
| 6 | 20678673 | Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study. | Clin Ther | 2010 | https://conductscience.org/library/papers/20678673 | PubMed |
| 7 | 12925369 | Alzheimer disease in the US population: prevalence estimates using the 2000 census. | Arch Neurol | 2003 | https://conductscience.org/library/papers/12925369 | PubMed |
| 8 | 19042161 | Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial. | Lancet Neurol | 2009 | https://conductscience.org/library/papers/19042161 | PubMed |
| 9 | 19735164 | Donepezil treatment in severe Alzheimer's disease: a pooled analysis of three clinical trials. | Curr Med Res Opin | 2009 | https://conductscience.org/library/papers/19735164 | PubMed |
| 10 | 6496779 | A new rating scale for Alzheimer's disease. | Am J Psychiatry | 1984 | https://conductscience.org/library/papers/6496779 | PubMed |
| 11 | 10844704 | Measurement of progression in Alzheimer's disease: a clinician's perspective. | Stat Med | 2000 | https://conductscience.org/library/papers/10844704 | PubMed |
| 12 | 12456059 | Measuring cognition in advanced Alzheimer's disease for clinical trials. | J Neural Transm Suppl | 2002 | https://conductscience.org/library/papers/12456059 | PubMed |
| 13 | 16581404 | Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study. | Lancet | 2006 | https://conductscience.org/library/papers/16581404 | PubMed |
| 14 | 11502918 | A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. | Neurology | 2001 | https://conductscience.org/library/papers/11502918 | PubMed |
| 15 | 9236953 | The severe impairment battery: concurrent validity and the assessment of longitudinal change in Alzheimer's disease. The Alzheimer's Disease Cooperative Study. | Alzheimer Dis Assoc Disord | 1997 | https://conductscience.org/library/papers/9236953 | PubMed |
| 16 | 18560130 | Pooled analyses on cognitive effects of memantine in patients with moderate to severe Alzheimer's disease. | J Alzheimers Dis | 2008 | https://conductscience.org/library/papers/18560130 | PubMed |
| 17 | 15643047 | Investigating the effects of communication problems on caregiver burden. | J Gerontol B Psychol Sci Soc Sci | 2005 | https://conductscience.org/library/papers/15643047 | PubMed |
| 18 | 20220536 | The relationship of 60 disease diagnoses and 15 conditions to preference-based health-related quality of life in Ontario hospital-based long-term care residents. | Med Care | 2010 | https://conductscience.org/library/papers/20220536 | PubMed |
| 19 | 20392862 | Effects of oral rivastigmine on cognitive domains in mild-to-moderate Alzheimer's disease. | Am J Alzheimers Dis Other Demen | 2010 | https://conductscience.org/library/papers/20392862 | PubMed |
| 20 | 20580129 | Alzheimer's pathology in primary progressive aphasia. | Neurobiol Aging | 2012 | https://conductscience.org/library/papers/20580129 | PubMed |
Cited by52
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 82 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42562373 | How Life-Course Trajectories of Physical Activity Track With Cognitive Decline. | J Phys Act Health | 2026 | https://conductscience.org/library/papers/42562373 | PubMed |
| 42356806 | Enhancing Early Detection of Alzheimer's Disease: An Ensemble Model for Multi-Domain Cognitive Assessment Using Voice and Video. | Sensors (Basel) | 2026 | https://conductscience.org/library/papers/42356806 | PubMed |
| 42301821 | Considerations for the selection and phenotyping of mouse models for the study of Alzheimer's disease. | STAR Protoc | 2026 | https://conductscience.org/library/papers/42301821 | PubMed |
| 42208039 | Recruitment and Participation of Black Home Health Care Patients in Speech-Based Cognitive Research: Mixed Methods Feasibility Study. | JMIR Form Res | 2026 | https://conductscience.org/library/papers/42208039 | PubMed |
| 42131727 | Functional ability in cognitive complaints: The role of neuropsychiatric and cognitive factors in community-dwelling older adults. | Alzheimers Dement Behav Socioecon Aging | 2025 | https://conductscience.org/library/papers/42131727 | PubMed |
| 41801850 | Timed image naming evaluation for adults (TIME) using BOSS images. | PLoS One | 2026 | https://conductscience.org/library/papers/41801850 | PubMed |
| 41403033 | Speech and language outcome measures in clinical trials of Alzheimer's and Parkinson's diseases. | Expert Rev Neurother | 2026 | https://conductscience.org/library/papers/41403033 | PubMed |
| 41302276 | Linguistic Markers in Spontaneous Speech: Insights into Subjective Cognitive Decline (Review). | Healthcare (Basel) | 2025 | https://conductscience.org/library/papers/41302276 | PubMed |
| 40913642 | Language dysfunction as a primary feature of cognitive decline in neurological populations. | J Neural Transm (Vienna) | 2026 | https://conductscience.org/library/papers/40913642 | PubMed |
| 40249550 | Visuospatial impairment in dementia: a new index to improve the clinical diagnosis of Alzheimer's disease. | Aging Clin Exp Res | 2025 | https://conductscience.org/library/papers/40249550 | PubMed |
| 39796512 | Mechanistic and Therapeutic Insights into Flavonoid-Based Inhibition of Acetylcholinesterase: Implications for Neurodegenerative Diseases. | Nutrients | 2024 | https://conductscience.org/library/papers/39796512 | PubMed |
| 39684990 | Perceived Training Needs of the Informal Caregivers of Older Adults: A Cross-Sectional Study. | Healthcare (Basel) | 2024 | https://conductscience.org/library/papers/39684990 | PubMed |
| 39163290 | Speech-related parameters are sensitive measures of acetylcholinesterase inhibitor therapy in mild Alzheimer's disease. | PLoS One | 2024 | https://conductscience.org/library/papers/39163290 | PubMed |
| 39114543 | Language Markers of Dementia and Their Role in Early Diagnosis of Alzheimer's Disease: Exploring Grammatical and Syntactic Competence via Sentence Repetition. | J Alzheimers Dis Rep | 2024 | https://conductscience.org/library/papers/39114543 | PubMed |
| 39028554 | Algorithmic Spaced Retrieval Enhances Long-Term Memory in Alzheimer Disease: Case-Control Pilot Study. | JMIR Form Res | 2024 | https://conductscience.org/library/papers/39028554 | PubMed |
| 37389678 | Validation of the test for finding word retrieval deficits (WoFi) in detecting Alzheimer's disease in a naturalistic clinical setting. | Eur J Ageing | 2023 | https://conductscience.org/library/papers/37389678 | PubMed |
| 37341896 | Turning the Spotlight to Cholinergic Pharmacotherapy of the Human Language System. | CNS Drugs | 2023 | https://conductscience.org/library/papers/37341896 | PubMed |
| 37035940 | Complementary auditory and Visual Naming Tests: Revised and updated for ages 16-55 years. | Clin Neuropsychol | 2024 | https://conductscience.org/library/papers/37035940 | PubMed |
| 36819782 | A Multifunctional (-)-Meptazinol-Serotonin Hybrid Ameliorates Oxidative Stress-Associated Apoptotic Neuronal Death and Memory Deficits via Activating the Nrf2/Antioxidant Enzyme Pathway. | Oxid Med Cell Longev | 2023 | https://conductscience.org/library/papers/36819782 | PubMed |
| 36737766 | The impact of depression on language function in individuals with Alzheimer's disease: a pre/post-treatment design. | Ann Gen Psychiatry | 2023 | https://conductscience.org/library/papers/36737766 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ACHE | 43 | PubTator's text mining | https://conductscience.org/library/genes/43 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23946647
GET https://conductscience.org/api/papers/v1/23946647/references?page=2